Cargando...
Advancing Novel PrEP Products – Alternatives to Non-Inferiority
With the scale-up of HIV pre-exposure prophylaxis (PrEP) with tenofovir (TDF) with or without emtricitabine (FTC), we have entered an era of highly effective HIV prevention with a growing pipeline of potential products to be studied. These studies are likely to be randomized trials with an oral TDF/...
Gardado en:
| Publicado en: | Stat Commun Infect Dis |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6731035/ https://ncbi.nlm.nih.gov/pubmed/31497242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1515/scid-2019-0011 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|